Progression of Idiopathic Pulmonary Fibrosis in patients with past occupational exposure to dusts

F. Liviero (Padova, Italy)

Source: International Congress 2017 – Shared exposures related to interstitial disease and airflow obstruction
Session: Shared exposures related to interstitial disease and airflow obstruction
Session type: Poster Discussion
Number: 407
Disease area: Interstitial lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
F. Liviero (Padova, Italy). Progression of Idiopathic Pulmonary Fibrosis in patients with past occupational exposure to dusts. 407

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of specific organic exposure on the prognosis in Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – IPF: from the bench to the bedside
Year: 2017


Occupational and environmental risk factors for Idiopathic Pulmonary Fibrosis in Australia
Source: International Congress 2018 – Occupational and environmental lung diseases: air quality and lung damage
Year: 2018



PP215 – The effect of long-term personal air pollution exposure on the inflammatory mediators in Idiopathic Pulmonary Fibrosis
Source: ERS Lung Science Conference 2021
Year: 2021

Impact of depression on patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2017 – Best clinical practice for the management of chronic lung diseases
Year: 2017

Impact of chronic air pollution exposure on non-cystic fibrosis bronchiectasis: Hit the road?
Source: Annual Congress 2013 –From air pollution during pregnancy to respiratory diseases at work
Year: 2013

Prevalence of occupational and environmental exposures in Australian patients with idiopathic pulmonary fibrosis (IPF)
Source: International Congress 2014 – Occupational asthma, abestosis and silicosis
Year: 2014

Occupational exposure and pulmonary fibrosis
Source: Annual Congress 2003 - Organic aerosols
Year: 2003


Association between severity of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Diffuse pulmonary ossification in Idiopathic Pulmonary Fibrosis: Forli 10-year experience
Source: International Congress 2017 – The wide spectrum of ILDs
Year: 2017


Platelet activation indices in patients with Idiopathic Pulmonary Fibrosis
Source: International Congress 2014 – ILDs 5
Year: 2014


Association between Pulmonary Infections and the Prognosis in Patients with Idiopathic Pulmonary Fibrosis
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Acute exacerbation of idiopathic pulmonary fibrosis associated with air pollution exposure
Source: Eur Respir J 2014; 43: 1124-1131
Year: 2014



Distribution of pleural plaques and pulmonary fibrosis due to asbestos exposure: Radiological patterns in asbestos-related disorders (ARDs)
Source: International Congress 2015 – Interstitial lung diseases I
Year: 2015


Treatment of Idiopathic Pulmonary Fibrosis
Source: Guideline 2015
Year: 2015

Association between mortality of Idiopathic Pulmonary Fibrosis and air Pollution levels in Madrid
Source: Virtual Congress 2021 – Interstitial lung disease around the world
Year: 2021


Baseline characteristics of idiopathic pulmonary fibrosis: analysis from the Australian Idiopathic Pulmonary Fibrosis Registry
Source: Eur Respir J , 49 (2) 1601592; DOI: 10.1183/13993003.01592-2016
Year: 2017




Air pollution and acute exacerbations of idiopathic pulmonary fibrosis: back to miasma?
Source: Eur Respir J 2014; 43: 956-959
Year: 2014


Organic dust toxic syndrome caused by occupational exposure to shrimpshell powder
Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers
Year: 2015


Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis?
Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis
Year: 2020